Blue Water Life Science Advisors, LP 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Blue Water Life Science Advisors, LP disclosed 10 US equity positions worth $124.7m in its Q1 2026 13F filing. The largest position was TXG at 18.6% of the reported book, followed by GH and CDNA.
What did Blue Water Life Science Advisors, LP own in Q1 2026? Top 10 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | TXG 10X GENOMICS INC | Healthcare | 18.6% | $23.1m | 1,090,000 | – | |
| 2 | GH GUARDANT HEALTH INC | Healthcare | 17.9% | $22.4m | 242,247 | – | |
| 3 | CDNA CAREDX INC | Healthcare | 13.0% | $16.2m | 935,000 | – | |
| 4 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 11.2% | $14.0m | 1,010,145 | – | |
| 5 | TWST TWIST BIOSCIENCE CORP | Healthcare | 10.5% | $13.1m | 276,000 | – | |
| 6 | PSNL PERSONALIS INC | Healthcare | 8.6% | $10.7m | 1,676,300 | – | |
| 7 | NTRA NATERA INC | Healthcare | 7.2% | $9.0m | 44,794 | – | |
| 8 | QTRX QUANTERIX CORP | Healthcare | 6.0% | $7.5m | 2,142,147 | – | |
| 9 | TEM TEMPUS AI INC | Healthcare | 5.7% | $7.1m | 156,412 | – | |
| 10 | BLLN BILLIONTOONE INC | 1.3% | $1.6m | 20,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.